Suchergebnisse - "Enomoto, Takayuki"

PubPharm (629)

101

MCM10 compensates for Myc-induced DNA replication stress in breast cancer stem-like cells

enthalten in: bioRxiv.org | 2021

von Murayama, T. | Takeuchi, Y. | Yamawaki, K. | +23

102

Characteristics and outcomes of women with adenocarcinoma versus squamous cell carcinoma of the vulva : A Japanese Gynecologic Oncology Group study

enthalten in: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology | 2021

von Nishio, S. | Matsuo, K. | Matsuzaki, S. | +7

103

The efficacy and safety profile of 2-weekly dosing of bevacizumab-containing chemotherapy for platinum-resistant recurrent ovarian cancer

enthalten in: International journal of clinical oncology | 2021

von Sekine, M. | Enomoto, T. | Watanabe, Y. | +3

ErratumIn: Int J Clin Oncol. 2021 Sep 9;:. - PMID 34499262

104

Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women : real-world data

enthalten in: The Lancet regional health. Western Pacific | 2021

von Sekine, M. | Yamaguchi, M. | Kudo, R. | +7

105

Clinicopathological characteristics and prognostic factors of ovarian granulosa cell tumors : A JSGO-JSOG joint study

enthalten in: Gynecologic oncology | 2021

von Ebina, Y. | Yamagami, W. | Kobayashi, Y. | +5

106

Proposing a molecular classification associated with hypercoagulation in ovarian clear cell carcinoma

enthalten in: Gynecologic oncology | 2021

von Tamura, R. | Yoshihara, K. | Matsuo, K. | +15

107

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer : Open-Label, Randomized Trial in Japan (NINJA)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Hamanishi, J. | Takeshima, N. | Katsumata, N. | +39

CommentIn: J Clin Oncol. 2021 Nov 20;39(33):3651-3655. - PMID 34529504

108

Correction to : The efficacy and safety profile of 2-weekly dosing of bevacizumab-containing chemotherapy for platinum-resistant recurrent ovarian cancer

enthalten in: International journal of clinical oncology | 2021

von Sekine, M. | Enomoto, T. | Watanabe, Y. | +3

ErratumFor: Int J Clin Oncol. 2021 Nov;26(11):2123-2129. - PMID 34308512

109

Clinical Significance of Mesenteric Lymph Node Involvement in the Pattern of Liver Metastasis in Patients with Ovarian Cancer

enthalten in: Annals of surgical oncology | 2021

von Tanaka, K. | Shimada, Y. | Nishino, K. | +5

CommentIn: Ann Surg Oncol. 2021 Nov;28(12):7614-7615. - PMID 33791903

110

Cervical Cancer Protection in Japan : Where Are We?

enthalten in: Vaccines | 2021

von Yagi, A. | Ueda, Y. | Kakuda, M. | +16